The Community Oncology Alliance (COA) meetings featured expert discussions around the evolving landscape of oncology care and ...

Results of a small study presented at the 66th American Society of Hematology Annual Meeting & Exposition suggest combining ...

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Recent discussions at an Institute for Value-Based Medicine event highlighted the significant potential of biosimilars in ...

Connect 2024 emphasized the transformative potential of artificial intelligence (AI) and predictive analytics in addressing ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Robin Glasgow, MBA, executive leadership advisor of Spencer Stuart, discusses the critical role of data in health care, ...

A new report from The Commonwealth Fund compares trends in health plan spending and employee costs for 2014 through 2023 ...